T-1201 / Taivex Therapeutics Corporation  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
T-1201 / Taivex Therapeutics Corporation
NCT04866641: Safety and Tolerability Study for T-1201 Injection 100 mg Kit in Patients With Advanced Solid Tumors

Recruiting
1
30
RoW
T-1201 Injection 100 mg Kit
Taivex Therapeutics Corporation
Advanced Solid Tumor
06/24
12/25

Download Options